150 related articles for article (PubMed ID: 32553759)
1. Therapeutic Decisions in Inflammatory Bowel Disease in the SARS-Cov-2 Pandemic.
Brain O; Satsangi J
Gastroenterology; 2021 Apr; 160(5):1883-1884. PubMed ID: 32553759
[No Abstract] [Full Text] [Related]
2. The Course of COVID-19 in Inflammatory Bowel Disease: Protective Role of TNF Antagonists.
Cappello M; Busacca A; Guida L
Gastroenterology; 2021 Apr; 160(5):1885-1886. PubMed ID: 32645320
[No Abstract] [Full Text] [Related]
3. Aminosalicylates and COVID-19: Facts or Coincidences?
Magro F; Dias CC; Morato M
Gastroenterology; 2021 Apr; 160(5):1884-1885. PubMed ID: 32553757
[No Abstract] [Full Text] [Related]
4. Management of patients with inflammatory bowel disease and outcomes during the first wave of the Covid-19 pandemic.
Viola A; Giambò F; Chiappetta MF; Costantino G; Pallio S; Fries W
Dig Liver Dis; 2021 Jun; 53(6):689-690. PubMed ID: 33832871
[No Abstract] [Full Text] [Related]
5. The COVID-19 pandemic shows us in which way the care of patients with inflammatory bowel disease should move.
Hernández Ramírez V; López Serrano P
Rev Esp Enferm Dig; 2021 Feb; 113(2):153-154. PubMed ID: 33467860
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations.
Bekic D; Belosic Halle Z
Scand J Gastroenterol; 2021 Jun; 56(6):656-660. PubMed ID: 33765405
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.
Schlabitz F; Teich N; Michl P; Walldorf J
Inflamm Bowel Dis; 2020 Aug; 26(9):e105-e106. PubMed ID: 32530027
[No Abstract] [Full Text] [Related]
8. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste.
Gower-Rousseau C; Fumery M; Pariente B;
Gastroenterology; 2021 Jan; 160(1):473-474. PubMed ID: 32389663
[No Abstract] [Full Text] [Related]
10. Establishing Safe Out-of-Hospital Infusion Centers May Improve the Quality of Care in Patients With IBD During the COVID-19 Pandemic.
Behzad C; Taheri H; Kashifard M
Inflamm Bowel Dis; 2020 Oct; 26(11):e140. PubMed ID: 32901275
[No Abstract] [Full Text] [Related]
11. Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.
Pasha SB; Fatima H; Ghouri YA
J Gastroenterol Hepatol; 2020 Aug; 35(8):1449-1450. PubMed ID: 32246874
[No Abstract] [Full Text] [Related]
12. Psychological Challenges for Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
Borghi L; Poli S; Furfaro F; Allocca M; Vegni EAM
Psychosom Med; 2021 May; 83(4):397-398. PubMed ID: 33234778
[No Abstract] [Full Text] [Related]
13. Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic".
Khorshid M; AbdAllah M
Inflamm Bowel Dis; 2021 Mar; 27(4):e39. PubMed ID: 33512472
[No Abstract] [Full Text] [Related]
14. Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
Garrido I; Lopes S; Macedo G
Inflamm Bowel Dis; 2020 Sep; 26(10):e114-e115. PubMed ID: 32737966
[No Abstract] [Full Text] [Related]
15. Balancing Risks and Benefits in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic.
Kotze PG; Peyrin-Biroulet L; Danese S
Gastroenterology; 2021 Jan; 160(1):472-473. PubMed ID: 32422207
[No Abstract] [Full Text] [Related]
16. Commenting on the Letter (Completing the Picture in Egypt: Response to "Inflammatory Bowel Diseases in Egypt During the COVID-19 Pandemic").
Eltabbakh M; Abd Alaty W; Sakr MA; Sherief AF
Inflamm Bowel Dis; 2021 Apr; 27(5):e66. PubMed ID: 33512507
[No Abstract] [Full Text] [Related]
17. Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry.
Windsor JW; Underwood FE; Brenner E; Colombel JF; Kappelman MD; Ungaro R; Zhang X; Kaplan GG
Am J Gastroenterol; 2020 Nov; 115(11):1923-1924. PubMed ID: 33156119
[No Abstract] [Full Text] [Related]
18. IBD in the COVID-19 era: the value of international collaboration.
Brenner EJ; Ungaro RC; Colombel JF; Kappelman MD
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):887-888. PubMed ID: 32941833
[No Abstract] [Full Text] [Related]
19. Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic.
Jena A; Kumar-M P; Singh AK; Sharma V
Dig Liver Dis; 2021 Mar; 53(3):295-297. PubMed ID: 33132062
[No Abstract] [Full Text] [Related]
20. The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
Barberio B; Zingone F; Bertani L; Savarino E
Gastroenterology; 2021 Apr; 160(5):1903-1904. PubMed ID: 32687929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
